Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

104 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Primary tumor location and bevacizumab effectiveness in patients with metastatic colorectal cancer.
Boisen MK, Johansen JS, Dehlendorff C, Larsen JS, Østerlind K, Hansen J, Nielsen SE, Pfeiffer P, Tarpgaard LS, Holländer NH, Keldsen N, Hansen TF, Jensen BB, Jensen BV. Boisen MK, et al. Among authors: osterlind k. Ann Oncol. 2013 Oct;24(10):2554-2559. doi: 10.1093/annonc/mdt253. Epub 2013 Jul 17. Ann Oncol. 2013. PMID: 23864097 Free article. Clinical Trial.
Tissue microRNAs as predictors of outcome in patients with metastatic colorectal cancer treated with first line Capecitabine and Oxaliplatin with or without Bevacizumab.
Boisen MK, Dehlendorff C, Linnemann D, Nielsen BS, Larsen JS, Osterlind K, Nielsen SE, Tarpgaard LS, Qvortrup C, Pfeiffer P, Holländer NH, Keldsen N, Hansen TF, Jensen BB, Høgdall EV, Jensen BV, Johansen JS. Boisen MK, et al. Among authors: osterlind k. PLoS One. 2014 Oct 15;9(10):e109430. doi: 10.1371/journal.pone.0109430. eCollection 2014. PLoS One. 2014. PMID: 25329796 Free PMC article.
Initial treatment and survival in 4163 Danish patients with pancreatic cancer: A nationwide unselected real-world register study.
Rasmussen LS, Fristrup CW, Jensen BV, Pfeiffer P, Weber B, Yilmaz MK, Poulsen LØ, Ladekarl M, Østerlind K, Larsen JS, Skuladottir H, Hansen CP, Mortensen MB, Mortensen FV, Sall M, Detlefsen S, Bøgsted M, Falkmer UG. Rasmussen LS, et al. Among authors: osterlind k. Eur J Cancer. 2020 Apr;129:50-59. doi: 10.1016/j.ejca.2020.01.015. Epub 2020 Feb 29. Eur J Cancer. 2020. PMID: 32120275
Patterns of Palliative Chemotherapy and Survival in Patients With Pancreatic Cancer Focusing on Age: A Nationwide Real-World Danish Registry Study.
Rasmussen LS, Fristrup CW, Jensen BV, Pfeiffer P, Weber B, Yilmaz MK, Poulsen LØ, Ladekarl M, Østerlind K, Larsen JS, Skuladottir H, Bøgsted M, Falkmer UG. Rasmussen LS, et al. Among authors: osterlind k. Pancreas. 2021 May-Jun 01;50(5):685-695. doi: 10.1097/MPA.0000000000001833. Pancreas. 2021. PMID: 34016900
Proton pump inhibitor use and cancer mortality.
Tvingsholm SA, Dehlendorff C, Østerlind K, Friis S, Jäättelä M. Tvingsholm SA, et al. Among authors: osterlind k. Int J Cancer. 2018 Sep 15;143(6):1315-1326. doi: 10.1002/ijc.31529. Epub 2018 May 2. Int J Cancer. 2018. PMID: 29658114 Free PMC article.
Disparity in use of modern combination chemotherapy associated with facility type influences survival of 2655 patients with advanced pancreatic cancer.
Ladekarl M, Rasmussen LS, Kirkegård J, Chen I, Pfeiffer P, Weber B, Skuladottir H, Østerlind K, Larsen JS, Mortensen FV, Engberg H, Møller H, Fristrup CW. Ladekarl M, et al. Among authors: osterlind k. Acta Oncol. 2022 Mar;61(3):277-285. doi: 10.1080/0284186X.2021.2012252. Epub 2021 Dec 8. Acta Oncol. 2022. PMID: 34879787
The effect of postoperative gemcitabine on overall survival in patients with resected pancreatic cancer: A nationwide population-based Danish register study.
Skau Rasmussen L, Vittrup B, Ladekarl M, Pfeiffer P, Karen Yilmaz M, Østergaard Poulsen L, Østerlind K, Palnæs Hansen C, Bau Mortensen M, Viborg Mortensen F, Sall M, Detlefsen S, Bøgsted M, Wilki Fristrup C. Skau Rasmussen L, et al. Among authors: osterlind k. Acta Oncol. 2019 Jun;58(6):864-871. doi: 10.1080/0284186X.2019.1581374. Epub 2019 Mar 25. Acta Oncol. 2019. PMID: 30905248
Superiority of cisplatin or carboplatin in combination with teniposide and vincristine in the induction chemotherapy of small-cell lung cancer. A randomized trial with 5 years follow up.
Lassen U, Kristjansen PE, Osterlind K, Bergman B, Sigsgaard TC, Hirsch FR, Hansen M, Dombernowsky P, Hansen HH. Lassen U, et al. Among authors: osterlind k. Ann Oncol. 1996 Apr;7(4):365-71. doi: 10.1093/oxfordjournals.annonc.a010603. Ann Oncol. 1996. PMID: 8805928 Free article. Clinical Trial.
104 results